We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Attributes Savings of $11.8 Billion in Drug Costs to Generics
FDA Attributes Savings of $11.8 Billion in Drug Costs to Generics
The FDA estimates that its generic drug approval pathway — which led to a record-setting year of generic drug approvals in 2017 — helped consumers save $11.8 billion in drug costs through February 2018.